Table 2b.

Prevalence (%) of U.S. women of lifetime absolute risks (%) of breast cancer by race and age

	≥6.00	95% CI	≥8.00	95% CI	≥10.00	95% CI	≥12.00	95% CI	≥14.00	95% CI	≥16.00	95% CI
All Women
30–39 years	93.5	92.9–94.1	72.4	71.2–73.6	47.6	46.2–48.9	18.3	17.3–19.4	5.9	5.2–6.7	4.5	3.9–5.1
40–49 years	95.5	94.9–96.0	69.9	68.4–71.3	41.8	40.3–43.2	20.5	19.5–21.7	10.4	9.6–11.3	7.0	6.4–7.8
50–59 years	81.3	80.0–82.4	49.6	48.0–51.2	22.3	20.9–23.7	12.6	11.6–13.7	8.9	8.1–9.9	4.6	4.0–5.2
60–69 years	48.9	47.0–50.8	18.8	17.3–20.5	10.8	9.7–12.1	6.4	5.5–7.4	2.8	2.3–3.5	2.1	1.6–2.6
70–84 years	10.6	9.6–11.8	4.3	3.7–5.1	1.7	1.4–2.2	0.8	0.6–1.2	0.4	0.2–0.7	0.3	0.1–0.5
White Non-Hispanic
30–39 years	100.0	NA§	83.8	82.5–85.1	63.8	62.1–65.5	24.4	23.0–26.0	7.7	6.7–8.8	6.3	5.5–7.3
40–49 years	100.0	NA	77.6	76.1–79.0	51.9	50.2–53.6	25.4	24.0–26.8	12.8	11.7–13.9	9.3	8.4–10,3
50–59 years	85.2	83.8–86.4	54.7	52.8–56.5	26.5	24.9–28.1	15.2	14.0–16.5	11.2	10.1–12.3	5.8	5.0–6.6
60–69 years	53.0	50.8–55.2	21.8	19.9–23.7	13.0	11.6–14.5	7.7	6.7–9.0	3.4	2.7–4.1	2.4	1.9–3.1
70–84 years	12.2	11.0–13.5	5.0	4.3–5.9	2.0	1.6–2.6	1.0	0.7–1.4	0.5	0.3–0.9	0.3	0.1–0.6
Black Non-Hispanic
30–39 years	100.0	NA	63.9	60.9–66.8	4.9	3.8–6.4	2.8	1.8–4.3	2.8	1.7–4.2	0.6	0.2–1.4
40–49 years	100.0	NA	68.2	64.7–71.5	11.8	9.7–14.2	5.4	4.0–7.2	4.5	3.2–6.1	0.5	0.1–1.3
50–59 years	88.0	85.3–90.2	42.8	39.3–46.4	8.0	6.0–10.6	4.9	3.2–7.3	0.7	0.1–2.0	0.5	0.1–1.6
60–69 years	40.6	35.9–45.4	6.2	3.8–9.6	3.2	1.6–5.7	1.2	0.3–3.3	1.0	0.1–3.1	1.0	0.1–3.1
70–84 years	4.0	2.0–7.0	0.6	0.0–3.1	0.6	0.0–3.1	0.0	NA	0.0	NA	0.0	NA
Hispanic
30–39 years	55.1	52.0–58.1	22.0	19.5–24.8	3.7	2.7–5.0	2.5	1.7–3.5	1.0	0.5–1.9	0.2	0.0–0.7
40–49 years	57.4	53.9–60.9	19.8	17.2–22.6	8.3	6.7–10.4	4.8	3.5–6.6	1.4	0.7–2.7	0.3	0.1–0.9
50–59 years	35.1	30.4–40.1	11.7	9.1–14.9	5.8	3.9–8.3	1.6	0.8–3.3	0.5	0.1–1.4	0.5	0.1–1.4
60–69 years	15.4	11.5–20.4	7.0	4.2–10.9	1.6	0.6–3.2	1.0	0.3–2.5	1.0	0.3–2.5	0.7	0.1–2.0
70–84 years	1.0	0.3–2.6	0.1	0.0–1.1	0.1	0.0–1.1	0.1	0.0–1.1	0.0	NA	0.0	NA

^§Not available